Genetic causes of bladder cancer narrowed

March 2013
Medical Device Daily;3/27/2013, Vol. 17 Issue 59, Special section p1
This article focuses on a study which investigated the role of the G-protein signaling pathway in the development of bladder cancer.


Related Articles

  • The Cancer Genome Atlas: Bladder Cancer. Goodman, Alice // Oncology Pharmacist;May2014, Vol. 7 Issue 2, p13 

    No abstract available.

  • The Cancer Genome Atlas: Bladder Cancer.  // Oncology Nurse-APN/PA;Mar/Apr2014, Vol. 7 Issue 2, p11 

    No abstract available.

  • The Cancer Genome Atlas Project Explores Bladder Cancer.  // Personalized Medicine in Oncology;Apr2014, Vol. 3 Issue 2, p116 

    No abstract available.

  • Genetic instability in urinary bladder cancer: An evolving hallmark. Wadhwa, N.; Mathew, B. B.; Jatawa, S. K.; Tiwari, A. // Journal of Postgraduate Medicine;Oct-Dec2013, Vol. 59 Issue 4, p284 

    Bladder cancer is a major health-care concern. A successful treatment of bladder cancer depends on its early diagnosis at the initial stage. Genetic instability is an essential early step toward the development of bladder cancer. This instability is found more often at the chromosomal level than...

  • Antioncogenic Effects of Transient Receptor Potential Vanilloid 1 in the Progression of Transitional Urothelial Cancer of Human Bladder. Santoni, Giorgio; Caprodossi, Sara; Farfariello, Valerio; Liberati, Sonia; Gismondi, Angela; Amantini, Consuelo // ISRN Urology;2012, p1 

    The progression of normal cells to a tumorigenic and metastatic state involves the accumulation of mutations in multiple key signaling proteins, encoded by oncogenes and tumor suppressor genes. Recently, members of the TRP channel family have been included in the oncogenic and tumor suppressor...

  • Emerging Critical Role of Molecular Testing in Diagnostic Genitourinary Pathology. Netto, George J.; Cheng, Liang // Archives of Pathology & Laboratory Medicine;Apr2012, Vol. 136 Issue 4, p372 

    Context.--The unprecedented advances in cancer genetics and genomics are rapidly affecting clinical management and diagnostics in solid tumor oncology. Molecular diagnostics is now an integral part of routine clinical management in patients with lung, colon, and breast cancer. In sharp contrast,...

  • Effect of PTEN Gene Mutations and Environmental Risk Factors on the Progression and Prognosis of Bladder Cancer. MASHHADI, Rahil; POURMAND, Gholamreza; MEHRSAI, Abdolrasoul; PAKDEL, Saeed; DIALAMEH, Hossein; AHMADI, Ayat; SALEM, Sepehr; SALIMI, Elaheh; MAHBOUBI, Ramina // Iranian Journal of Public Health;Jan2014, Vol. 43 Issue 1, p56 

    Background: Bladder cancer is the most frequent genitourinary malignancy in Iran. Environmental and genetic factors are the two factors linked with bladder cancer expansion. The aim of this study was to investigate the role of PTEN gene and environmental risk factors on the progression and...

  • Gene set breaks high-grade BCa into two subtypes. Overmyer, Mac // Urology Times;4/15/2014, Vol. 42 Issue 5, p22 

    The article reports on the identification of a discrete set of genes that segregate high-grade bladder cancer into two distinct subtypes, basal-like and luminal, by researchers at the University of North Carolina School of Medicine in Chapel Hill. It notes that each of the subtypes appears to...

  • Small Cell Carcinoma of the Urinary Bladder: A Rare, Aggressive Neuroendocrine Malignancy. Xiangrong Zhao; Flynn, Ethan A. // Archives of Pathology & Laboratory Medicine;Nov2012, Vol. 136 Issue 11, p1451 

    Small cell carcinoma of the urinary bladder is a rare, often fatal, disease. Its presenting symptoms and gross morphology are similar to those of conventional urothelial carcinoma, whereas its prognosis is much poorer with frequent metastasis. Small cell carcinoma of the urinary bladder shares...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics